On assessing survival benefit of immunotherapy using long‐term restricted mean survival time (Q61029)

From MaRDI portal
Revision as of 16:42, 25 April 2024 by Import240425040427 (talk | contribs) (Added link to MaRDI item.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
On assessing survival benefit of immunotherapy using long‐term restricted mean survival time
scientific article

    Statements

    DOI
    10.1002/sim.9662
    0 references
    volume
    42
    0 references
    issue
    8
    0 references
    page(s)
    1139-1155
    0 references
    publication date
    18 January 2023
    0 references
    author
    Miki Horiguchi
    0 references
    Lu Tian
    0 references
    Hajime Uno
    0 references
     
    Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Item:Q61029&oldid=33783883"
    Powered by MediaWiki